Expression of luminal (FOXA1, GATA3, PPARG, etc.)and basal (KRT1, KRT5, KRT6A, etc.)[4, 5] genes have been used to molecularly characterize muscle invasive BLCA. This evidence concerns the gene GATA3 and bladder transitional cell carcinoma.